Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-079777·Ernexa Therapeutics Inc.
Schedule 13G ownership disclosure
ERNEXA THERAPEUTICS INC
Common Stock, par value $0.005 per share · CUSIP: 114082308
Event date: 2025-07-28
- Filing-level shares
- 315,779.00
- Percent of class
- 4.1%
- IAF, LLC
Shares: 315,779.00 · Class: 4.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-079777
- Form type
- SCHEDULE 13G/A
- Filer
- Ernexa Therapeutics Inc.
- CIK
- CIK 748592
- Filed
- Aug 18, 2025
- Reporting period
- Jul 28, 2025
- Description
- Schedule 13G beneficial ownership